Trial intelligence / Profile preview

Efficacy and Safety of Human Prothrombin Complex in Hemophilia B

CTR20182080Phase 3Completed

Sponsor
Pacific Shuanglin Bio-pharmacy
Start
Jan 2019
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of prothrombin complex concentrate, human in hemophilia B (HB), sponsored by Pacific Shuanglin Bio-pharmacy. Started Jan 2019; status: completed.

02

Drugs

prothrombin complex concentrate, human
03

Conditions

hemophilia B (HB)

Beyond the preview

Go deeper on CTR20182080.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20182080.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call